PANTHERx® Specialty Pharmacy’s Chairman & CEO, Dr. Gordon J. Vanscoy will be presenting a discussion on specialty pharmacy’s evolving role in rare disorders and orphan drugs at the upcoming 7th Orphan Drugs & Rare Diseases Americas West Coast Congress from June 25th – 26th in San Diego, California.
The Orphan Drugs & Rare Diseases Global Congress 2018 Americas provides a unique platform for the convergence of stakeholders in the orphan drug industry to discuss and network with top tier government, hospital, pharmaceutical, biopharmaceutical, non-profit, and orphan drug development organizations, as well as regional and local manufacturers. The agenda addresses the driving macroeconomic factors, policies and issues that will steer the development of orphan drugs globally including commercialization, policies, reimbursement, pricing and more.
Dr. Vanscoy has spent over three decades nurturing and building successful medical and pharmaceutical service businesses, including PANTHERx®, The Rare Disease Specialty Pharmacy®, and RareMed Solutions, a rare and orphan focused hub service. Read more about Dr. Vanscoy’s achievements at https://www.pantherspecialty.com/leadership/gordon-j-vanscoy/. Registration is still open at http://www.orphandrugsamericas.com/bookings/.